Form 8-K - Current report:
SEC Accession No. 0001087294-13-000011
Filing Date
2013-08-09
Accepted
2013-08-09 17:13:20
Documents
2
Period of Report
2013-08-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a06302013-8kearningsrelease.htm 8-K 225190
2 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
  Complete submission text file 0001087294-13-000011.txt   278357
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 131027600
SIC: 2834 Pharmaceutical Preparations